Compare UNF & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UNF | VERA |
|---|---|---|
| Founded | 1936 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.4B |
| IPO Year | N/A | 2021 |
| Metric | UNF | VERA |
|---|---|---|
| Price | $207.55 | $44.46 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | ★ $180.75 | $76.60 |
| AVG Volume (30 Days) | 183.3K | ★ 1.1M |
| Earning Date | 01-07-2026 | 02-25-2026 |
| Dividend Yield | ★ 0.70% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 7.56 | N/A |
| Revenue | ★ $2,448,762,000.00 | N/A |
| Revenue This Year | $3.40 | N/A |
| Revenue Next Year | $3.54 | N/A |
| P/E Ratio | $27.44 | ★ N/A |
| Revenue Growth | ★ 0.41 | N/A |
| 52 Week Low | $147.66 | $18.53 |
| 52 Week High | $228.93 | $56.05 |
| Indicator | UNF | VERA |
|---|---|---|
| Relative Strength Index (RSI) | 61.12 | 44.27 |
| Support Level | $205.21 | $43.94 |
| Resistance Level | $210.00 | $47.95 |
| Average True Range (ATR) | 5.14 | 2.47 |
| MACD | -0.77 | -0.65 |
| Stochastic Oscillator | 57.06 | 10.72 |
UniFirst Corp provides uniform and workwear programs, facility management, and safety supplies and services across North America. It designs, manufactures, rents, cleans, and sells uniforms and protective clothing, including flame-resistant and high-visibility garments. It also offers industrial wiping products, floor mats, cleaning supplies, first aid cabinets, and fire protection services such as inspection and maintenance. Serving various industries, the company provides customized uniforms and specialized cleaning for nuclear and cleanroom facilities. It operates through three segments: Uniform & Facility Service Solutions, First Aid & Safety Solutions, and Other, with the majority of revenue from Uniform & Facility Service Solutions.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.